Luc Desnoyers, PhD

Luc Desnoyers serves as the Senior Vice President of Translational Research and Discovery at Neuron23. His focus is on leading the biomarker and diagnostics efforts to move programs from the late-stage research through to clinical proof of concept. 

Prior to joining Neuron23, Dr. Desnoyers spent 9 years at CytomX Therapeutics, where he held roles of increasing responsibility. Most recently, Dr. Desnoyers served as Vice-President of Translational Sciences, during which he established and led the biomarker group accountable for biomarker and diagnostics strategies for all clinical programs. He has 1669 patents and 21 top-tier publications to his name.

Before joining CytomX, Dr. Desnoyers spent 14 years at Genentech working in multiple therapeutic areas and occupying different roles from early discovery to oncology biomarker for clinical development. Dr. Desnoyers completed his post-doctoral fellow at UT Southwestern Medical Center with Drs Brown and Goldstein and holds a Ph.D. in Biochemistry from University of Montreal.